Under-Eye Hyperpigmentation: How a NYC Dermatologist Treats Infraorbital Darkness in Skin of Color
Dark circles under the eyes are one of the most common concerns patients bring to a cosmetic dermatology consultation, and one of the most misunderstood. Concealer covers them, but nothing on a drugstore shelf meaningfully addresses the underlying cause. Many times, the issue is pigmentation, not just shadowing, and treating it well requires a specific approach.
Below, board-certified Manhattan dermatologist Dr. Brian Hibler explains what actually causes infraorbital hyperpigmentation, why laser choice matters more here than almost anywhere else on the face, and where the 1927 nanometer thulium wavelength fits in a treatment plan.
What infraorbital hyperpigmentation actually is
Infraorbital hyperpigmentation – the clinical term for darkness of the skin under the eyes – is one of several distinct causes of the appearance patients describe as “dark circles”. Truly pigmented dark circles are the result of excess melanin in the epidermis, the dermis, or both, and this pattern is significantly more common in patients with deeper skin tones. It is important to distinguish it from other causes of under-eye darkness that look similar but require different treatment. Superficial vascular congestion, deep tear-trough hollowing, and thin skin that reveals underlying orbital tissue all produce a similar visual effect, but the mechanisms and the appropriate treatments differ. For a broader overview of under-eye concerns, see Under-Eye Circles.
What causes infraorbital hyperpigmentation
Several factors contribute, and most patients have more than one. Understanding which apply in an individual case is the first step of any real treatment plan.
- Genetics and skin type. Patients with Fitzpatrick III through VI skin have more baseline melanin activity in the periorbital region, and a family history of under-eye darkness is common.
- Chronic sun exposure. The thin skin under the eye is particularly susceptible to UV-driven pigment, and patients often underprotect this area.
- Post-inflammatory hyperpigmentation. Chronic rubbing from allergies or eczema produces persistent pigment deposition that can outlast the underlying inflammation by months.
- Vascular contribution. Prominent superficial vessels or venous congestion can add a blue-purple tint that overlaps with, and often coexists with, true pigmentation.
- Structural concerns. Volume loss in the tear trough and midface creates shadow that appear visually as darkness even when the underlying skin color is normal.
An examination distinguishes these contributions before any treatment is chosen. Treating a shadow with a laser produces no improvement; treating pigment with filler makes the problem worse.
Why the 1927 nanometer thulium laser is well-suited to this problem
The 1927 nanometer wavelength is a non-ablative fractional thulium laser targeted primarily at water in the epidermis and superficial dermis. Its clinical value in infraorbital hyperpigmentation comes from three properties that align with the anatomy and the risk profile of the under-eye region.
First, the depth of penetration is shallow compared with longer-wavelength lasers. In the under-eye area, where skin is thin and the globe of the eye sits directly below, a shallower target zone is safer. Second, the fractional pattern treats a controlled fraction of the skin surface at a time, leaving intervening healthy tissue to drive rapid re-epithelialization. This shortens downtime and, more importantly in darker skin tones, reduces the risk of post-inflammatory hyperpigmentation (the paradoxical worsening of pigment that can follow an overly aggressive treatment). Third, the thulium wavelength produces effective clearance of superficial pigment without the deep thermal effect that drives melanocyte hyperactivity in Fitzpatrick IV through VI skin.
Dr. Hibler most commonly delivers the 1927 nanometer wavelength using the Fraxel Dual platform, which combines the 1927nm thulium laser with a 1550nm erbium laser for texture and deeper pigment. For patients who want a gentler, lower-downtime option or who are treating milder pigment, Clear + Brilliant laser offers a lighter fractional treatment that can be used on a maintenance rhythm. Which platform is right, at what settings, and at what interval is a decision made in consultation. For more on the principles that govern laser use in richer skin tones, see Skin of Color.
Where filler, vascular lasers, and other treatments fit
Because infraorbital darkness usually has more than one contributing cause, the best plans are combinations. The role of each additional tool depends on which contributing factor is dominant.
Filler for structural shadow
When a significant portion of the appearance is driven by tear-trough hollowing rather than by pigment, a small, precisely placed volume of hyaluronic acid filler can reduce shadow and dramatically improve the visual impression. Restraint is critical here – the under-eye is one of the least forgiving areas on the face, and overfilling produces puffiness, blue-gray discoloration from the Tyndall effect, and long-lasting distortion. Overfilling also leads to risks of filler migration, which is rare when filler is used conservatively in this location.
Vascular laser for the blue-purple component
When prominent superficial vessels contribute to the under-eye appearance, a vascular laser such as the VBeam pulsed dye laser can reduce the blue-purple hue that coexists with true pigmentation in many patients. Vascular lasers target hemoglobin rather than melanin, so they complement rather than replace the thulium approach. Care must be taken in the infraorbital area given the risks associated with treating near the eye.
PRP for skin quality
Platelet-rich plasma and biostimulatory treatments can improve the overall quality of thin under-eye skin, which reduces the visibility of underlying vasculature and tissue. These are supportive rather than definitive treatments for pigment, but they can be a useful part of a longer-arc plan.
The role of adjuvant topicals
Topicals do not replace in-office treatment for established infraorbital hyperpigmentation, but they meaningfully improve results when used consistently before and after laser sessions. The right combination depends on the patient’s baseline sensitivity and the specifics of the pigment pattern.
- Broad-spectrum tinted mineral sunscreen with iron oxides. This is the single most important topical for any patient with hyperpigmentation of any type. Iron oxides block the portion of visible light that drives melanin production – a wavelength that most non-tinted sunscreens do not filter.
- Topical vitamin C. An L-ascorbic acid formulation supports the skin’s own DNA repair, provides antioxidant protection, and modestly inhibits tyrosinase, the enzyme central to melanin production.
- Retinoids. Tretinoin or an over-the-counter retinal used carefully around the eye accelerates cell turnover and reduces epidermal pigment. Introduction should be cautious and gradual – the under-eye area is thin and irritation can trigger post-inflammatory hyperpigmentation of its own.
- Targeted pigment-modulating actives. Ingredients such as tranexamic acid, cysteamine, alpha arbutin, kojic acid, azelaic acid, and niacinamide can each play a role. Hydroquinone remains the reference standard for medical-grade pigment correction and can be used in the periocular area under physician supervision, in short cycles.
What treatment looks like in practice
A typical plan for infraorbital hyperpigmentation begins with a consultation to identify which of the contributing causes are dominant. If pigment is the primary driver, Dr. Hibler most often recommends a series of three 1927nm laser treatments spaced four to six weeks apart, alongside a supportive topical regimen and diligent sun protection. Downtime is typically two to four days of mild swelling and a bronzed, sandpapery texture. Results build gradually as new, less-pigmented epidermis is regenerated after each session.
In patients with a vascular contribution, a session of vascular laser may be added. In patients with tear-trough shadow, a conservative filler treatment may be planned once pigment has been reduced. The sequence matters – treating pigment first and then re-evaluating structural contribution produces better decisions about how much filler, if any, is needed. Results vary, and no plan guarantees a specific outcome, but a well-designed multimodal approach produces meaningful, durable improvement in the majority of appropriately selected patients.
FAQ
Can laser treatment safely lighten dark circles in dark skin?
Yes, when the right wavelength and settings are used. The 1927 nanometer thulium laser is particularly well-suited to melanin-rich skin because it treats superficial pigment without generating deep thermal effect that can trigger post-inflammatory hyperpigmentation. Provider experience with skin of color is critical – device selection, settings, spacing, and pre- and post-treatment protocols all matter more than the device itself.
How many sessions are needed to treat under-eye hyperpigmentation?
Most patients see meaningful improvement over a series of three 1927nm sessions spaced four to six weeks apart. Some patients require additional maintenance treatments once or twice a year, particularly if underlying contributing factors such as allergic rubbing or sun exposure are not fully controlled.
What is the difference between Fraxel Dual and Clear and Brilliant for this?
Both platforms can deliver the 1927 nanometer thulium wavelength. Fraxel Dual is a stronger fractional laser that produces greater improvement per session, with slightly longer downtime. The energy and density of treatment are typically greater; but with experience and in-depth knowledge of the device, the settings can be modified to gentler settings safe in any skin tone. Clear + Brilliant is a gentler treatment better suited to mild pigment, to patients who want minimal downtime, and to maintenance schedules. The right choice depends on the severity of pigment, the patient’s downtime tolerance, and long-term goals.
Will filler alone fix my under-eye darkness?
Filler is helpful when a meaningful portion of the appearance is driven by tear-trough hollowing. When the primary problem is pigment, filler does not correct it and can make it look worse by adding volume without addressing the color. An in-person evaluation determines which contribution is dominant before any treatment is chosen.
Is hydroquinone safe to use under the eyes?
Under physician supervision, and in short cycles, a thin layer of medical-grade hydroquinone can often be used carefully in the periocular area with moisturizer. It remains one of the most effective pigment-modulating ingredients available. Overuse and unsupervised long-term use should be avoided, and alternative agents such as tranexamic acid, thiamidol, and azelaic acid can be substituted for maintenance.
Can post-inflammatory hyperpigmentation under the eyes be prevented
Largely, yes. Prevention includes daily broad-spectrum tinted sunscreen, avoiding rubbing and picking of the area, treating underlying allergic or eczematous conditions actively, and being cautious with over-the-counter products that irritate thin skin. Once pigment has become established, treatment is more effective when started earlier rather than later.
For a private consultation on treating infraorbital hyperpigmentation with an approach tailored to individual skin type and anatomy, the next step is a visit at Dr. Hibler’s Manhattan practice. Schedule a consultation to begin.
At a Glance
Dr. Brian Hibler
- Board-Certified Dermatologist (Cornell)
- Cosmetic Fellowship–Training (Harvard)
- Castle Connolly Top Doctor
- NY Times Super Doctor
- 70+ Publications, 90+ International Lectures
- Learn more